Laboratory hematology, treatment, and prognosis of patients with hemophagocytic lymphohistiocytosis (HLH)* and hypersensitivity to mosquito bite (HMB) episodes related to EBV infection.

Abbreviations: M, male; F, female; Hb, hemoglobin; PL, platelet; Neu, neutrophil; TG, triglyceride; Fribi; fibrinogen; AST, aspartate aminotransferase; ALT, alanine aminotransferase; IVIG, intravenous immunoglobulin; ST, steroid prednisolone or dexamethasone; CsA, cyclosporine A; VP-16, etoposide; ND, not done; NSAID, Non-steroidal anti-inflammatory drug; CAEBV, Chronic active EBV infection.*The diagnosis criteria included fever, splenomegaly, cytopenia (affecting 2 of 3 lineages, Hb 500 ul/L and soluble CD25>2400 U/ml. Twelve patients with HLH reached at least 5 criteria without detectable soluble CD25.aThe normal range of fibrinogen, TG, ferritin, AST, and ALT was 190–380 mg/dL,